531 related articles for article (PubMed ID: 17867629)
1. Pre-ischemic administration of landiolol prevents ischemia-reperfusion injury in the rat heart.
Takahashi Y; Shibata T; Sasaki Y; Hirai H; Takemura S; Minamiyama Y; Sakaguchi M; Suehiro S
Osaka City Med J; 2007 Jun; 53(1):9-16. PubMed ID: 17867629
[TBL] [Abstract][Full Text] [Related]
2. Landiolol has cardioprotective effects against reperfusion injury in the rat heart via the PKCepsilon signaling pathway.
Takahashi Y; Takemura S; Minamiyama Y; Shibata T; Hirai H; Sasaki Y; Sakaguchi M; Suehiro S
Free Radic Res; 2007 Jul; 41(7):757-69. PubMed ID: 17577736
[TBL] [Abstract][Full Text] [Related]
3. Effects of landiolol on mechanical and metabolic changes in rat reperfused ischaemic hearts.
Sakanashi M; Sakanashi M; Sugahara K; Sakanashi M
Clin Exp Pharmacol Physiol; 2007; 34(1-2):55-60. PubMed ID: 17201736
[TBL] [Abstract][Full Text] [Related]
4. Landiolol, esmolol and propranolol protect from ischemia/reperfusion injury in isolated guinea pig hearts.
Kurosawa S; Kanaya N; Niiyama Y; Nakayama M; Fujita S; Namiki A
Can J Anaesth; 2003 May; 50(5):489-94. PubMed ID: 12734159
[TBL] [Abstract][Full Text] [Related]
5. Myocardial protection: the efficacy of an ultra-short-acting beta-blocker, esmolol, as a cardioplegic agent.
Bessho R; Chambers DJ
J Thorac Cardiovasc Surg; 2001 Nov; 122(5):993-1003. PubMed ID: 11689806
[TBL] [Abstract][Full Text] [Related]
6. [Mechanism of cardioprotection against ischemia/reperfusion injury by valsartan: an experiment with isolated rat hearts].
Zhang YJ; Bai XJ; Qi ZM; Wang HX
Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(47):3350-3. PubMed ID: 16409843
[TBL] [Abstract][Full Text] [Related]
7. Landiolol does not enhance the effect of ischemic preconditioning in isolated rat hearts.
Yu S; Katoh T; Okada H; Makino H; Mimuro S; Sato S
J Anesth; 2010 Apr; 24(2):208-14. PubMed ID: 20084408
[TBL] [Abstract][Full Text] [Related]
8. The protective effect of prior ischemia reperfusion adenosine A1 or A3 receptor activation in the normal and hypertrophied heart.
Hochhauser E; Leshem D; Kaminski O; Cheporko Y; Vidne BA; Shainberg A
Interact Cardiovasc Thorac Surg; 2007 Jun; 6(3):363-8. PubMed ID: 17669867
[TBL] [Abstract][Full Text] [Related]
9. Ischemic preconditioning in immature hearts: mechanism and compatibility with cardioplegia.
Zhu B; Min S; Long C; Ye T
Chin Med J (Engl); 2003 Feb; 116(2):253-7. PubMed ID: 12775242
[TBL] [Abstract][Full Text] [Related]
10. A comparison between ranolazine and CVT-4325, a novel inhibitor of fatty acid oxidation, on cardiac metabolism and left ventricular function in rat isolated perfused heart during ischemia and reperfusion.
Wang P; Fraser H; Lloyd SG; McVeigh JJ; Belardinelli L; Chatham JC
J Pharmacol Exp Ther; 2007 Apr; 321(1):213-20. PubMed ID: 17202401
[TBL] [Abstract][Full Text] [Related]
11. [Cardiac dysfunction and endogenous cytokines in global ischemia and reperfusion injury].
Kamikubo Y
Hokkaido Igaku Zasshi; 1993 Nov; 68(6):813-26. PubMed ID: 8112707
[TBL] [Abstract][Full Text] [Related]
12. Cardioprotection: intermittent ventricular fibrillation and rapid pacing can induce preconditioning in the blood-perfused rat heart.
Hearse DJ; Ferrari R; Sutherland FJ
J Mol Cell Cardiol; 1999 Nov; 31(11):1961-73. PubMed ID: 10591023
[TBL] [Abstract][Full Text] [Related]
13. Preconditioning improves cardiac function after global ischemia, but not after cold cardioplegia.
Valen G; Takeshima S; Vaage J
Ann Thorac Surg; 1996 Nov; 62(5):1397-403. PubMed ID: 8893575
[TBL] [Abstract][Full Text] [Related]
14. Modulation of cardioprotective effect of ischemic pre- and postconditioning in the hyperhomocysteinemic rat heart.
Balakumar P; Rohilla A; Singh G; Singh K; Singh M
Methods Find Exp Clin Pharmacol; 2009 Mar; 31(2):71-9. PubMed ID: 19455261
[TBL] [Abstract][Full Text] [Related]
15. Sivelestat reduces myocardial ischemia and reperfusion injury in rat hearts even when administered after onset of myocardial ischemia.
Kambe M; Bessho R; Fujii M; Ochi M; Shimizu K
Interact Cardiovasc Thorac Surg; 2009 Jun; 8(6):629-34. PubMed ID: 19279053
[TBL] [Abstract][Full Text] [Related]
16. Endothelin-1 increases susceptibility of isolated rat hearts to ischemia/reperfusion injury by reducing coronary flow.
de Groot MC; Illing B; Horn M; Urban B; Haase A; Schnackerz K; Neubauer S
J Mol Cell Cardiol; 1998 Dec; 30(12):2657-68. PubMed ID: 9990537
[TBL] [Abstract][Full Text] [Related]
17. Myocardial protective effect of FR167653; a novel cytokine inhibitor in ischemic-reperfused rat heart.
Aleshin A; Sawa Y; Ono M; Funatsu T; Miyagawa S; Matsuda H
Eur J Cardiothorac Surg; 2004 Nov; 26(5):974-80. PubMed ID: 15519192
[TBL] [Abstract][Full Text] [Related]
18. Experimental study of intermittent crossclamping with fibrillation and myocardial protection: reduced injury from shorter cumulative ischemia or intrinsic protective effect?
Bessho R; Chambers DJ
J Thorac Cardiovasc Surg; 2000 Sep; 120(3):528-37. PubMed ID: 10962415
[TBL] [Abstract][Full Text] [Related]
19. Ischemic preconditioning, cardioplegia or both? Differing approaches to myocardial and vascular protection.
Kolocassides KG; Galiñanes M; Hearse DJ
J Mol Cell Cardiol; 1996 Mar; 28(3):623-34. PubMed ID: 9011645
[TBL] [Abstract][Full Text] [Related]
20. Dendroaspis natriuretic peptide protects the post-ischemic myocardial injury.
Ha KC; Piao CS; Chae HJ; Kim HR; Chae SW
Regul Pept; 2006 Jan; 133(1-3):13-9. PubMed ID: 16289365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
